Mycobacterium tuberculosis “Beijing” epidemics: A race against mutations? - 02/02/12
Doi : 10.1016/j.tube.2011.09.004
P. Bhatter, A. Chatterjee, N. Mistry ⁎ 
The Foundation For Medical Research, 84-A, R.G.Thadani Marg, Worli, Mumbai 400018, India
Corresponding author. Tel.: +91 22 24934989.Summary |
Multi Drug Resistant Tuberculosis Beijing strains exhibit different drug-resistance mutations (DRM) in different locations. By comparing DRM in Beijing reported from Tuberculosis endemic and epidemic locations, we propose that DRM selected in a population cannot tolerate biologically available drugs in different populations resulting in further evolution through novel DRM.
Le texte complet de cet article est disponible en PDF.Keywords : Mycobacterium tuberculosis, Multi-drug resistant tuberculosis (MDRTB), Beijing, Double mutation, Minimum inhibitory concentration (MIC), Drug resistance
Plan
© 2011
Elsevier Ltd. Tous droits réservés.
Vol 92 - N° 1
P. 92-94 - janvier 2012 Retour au numéro
Article précédent
- Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance
- Mirko Zimic, Patricia Fuentes, Robert H. Gilman, Andrés H. Gutiérrez, Daniela Kirwan, Patricia Sheen
- Is RORγ a therapeutic target for treating Mycobacterium tuberculosis infections?
- Paul W. Baures
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?